Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdalena Zoledziewska

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Medical Hypotheses|May 27, 2024
Is Epstein Barr virus latency protective against type 1 diabetes?Magdalena Zoledziewska
Multiple Sclerosis and Related Disorders|June 1, 2020
A new mouse model for human immune system-related translational studiesMagdalena Zoledziewska
Pediatric Endocrinology Reviews : PER|August 3, 2020
Genetics of Neonatal HypoglycaemiaMagdalena Zoledziewska
Autoimmunity Reviews|June 10, 2019
The gut microbiota perspective for interventions in MSMagdalena Zoledziewska
Nutrients|November 27, 2024
Propionic Acid Impact on Multiple Sclerosis: Evidence and ChallengesLorena Lorefice, Magdalena Zoledziewska
Neurodegenerative Disease Management|November 27, 2024
Gut microbiota and multiple sclerosis: a potential diagnostic and prognostic marker?Magdalena Zoledziewska, Lorena Lorefice
Multiple Sclerosis and Related Disorders|June 24, 2024
Intermittent and periodic fasting - Evidence and perspectives in multiple sclerosisLorena Lorefice, Maristella Pitzalis, Magdalena Zoledziewska
Genes|May 27, 2026
Type 1 Diabetes and Multiple Sclerosis Share General Autoimmunity Genetic VariationMaristella Steri, Alessandro Testori, Valeria Orrù, et al.
Kidney Diseases (Basel, Switzerland)|January 19, 2018
Genome-Wide Analysis Studies and Chronic Kidney DiseaseDoloretta Piras, Magdalena Zoledziewska, Francesco Cucca, et al.
Multiple Sclerosis and Related Disorders|March 31, 2023
Disease-modifying therapy for multiple sclerosis: Implications for gut microbiotaSilvy Pilotto, Magdalena Zoledziewska, Giuseppe Fenu, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Medical Hypotheses|May 27, 2024
Is Epstein Barr virus latency protective against type 1 diabetes?Magdalena Zoledziewska
Multiple Sclerosis and Related Disorders|June 1, 2020
A new mouse model for human immune system-related translational studiesMagdalena Zoledziewska
Pediatric Endocrinology Reviews : PER|August 3, 2020
Genetics of Neonatal HypoglycaemiaMagdalena Zoledziewska
Autoimmunity Reviews|June 10, 2019
The gut microbiota perspective for interventions in MSMagdalena Zoledziewska
Nutrients|November 27, 2024
Propionic Acid Impact on Multiple Sclerosis: Evidence and ChallengesLorena Lorefice, Magdalena Zoledziewska
Neurodegenerative Disease Management|November 27, 2024
Gut microbiota and multiple sclerosis: a potential diagnostic and prognostic marker?Magdalena Zoledziewska, Lorena Lorefice
Multiple Sclerosis and Related Disorders|June 24, 2024
Intermittent and periodic fasting - Evidence and perspectives in multiple sclerosisLorena Lorefice, Maristella Pitzalis, Magdalena Zoledziewska
Genes|May 27, 2026
Type 1 Diabetes and Multiple Sclerosis Share General Autoimmunity Genetic VariationMaristella Steri, Alessandro Testori, Valeria Orrù, et al.
Kidney Diseases (Basel, Switzerland)|January 19, 2018
Genome-Wide Analysis Studies and Chronic Kidney DiseaseDoloretta Piras, Magdalena Zoledziewska, Francesco Cucca, et al.
Multiple Sclerosis and Related Disorders|March 31, 2023
Disease-modifying therapy for multiple sclerosis: Implications for gut microbiotaSilvy Pilotto, Magdalena Zoledziewska, Giuseppe Fenu, et al.
Pageof 7